Firethorn Wealth Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
SGH
EWM
LHWM
AIC
MWA
FA
MAM
FFA
RWA
Firethorn Wealth Partners's XBI Position: Q3 2026 in Review
Firethorn Wealth Partners increased its State Street SPDR S&P Biotech ETF (XBI) stake by 1.7% in Q3 2026, buying an estimated $27K and bringing the position to 10,378 shares worth $1.64M. The position accounts for 0.52% of the portfolio, ranked #43.
Firethorn Wealth Partners first reported a position in XBI in Q1 2022 and has held it in 19 quarters since. 93 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Firethorn Wealth Partners held 10,378 shares of State Street SPDR S&P Biotech ETF worth $1.64M as of Q3 2026.
- Firethorn Wealth Partners bought 171 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $27K.
- State Street SPDR S&P Biotech ETF made up 0.52% of Firethorn Wealth Partners's portfolio in Q3 2026, its #43 holding.
- Firethorn Wealth Partners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 19 quarters since.
- 93 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Firethorn Wealth Partners's 13F filing for Q3 2026, filed 14 Oct 2026.